Next week, the Apeloa team is heading to Amsterdam for TIDES Europe 2026.
We are excited to sponsor this premier event. Come meet our team at Booth #909 at the RAI Amsterdam from November 3 to 5 to discuss peptide development, oligonucleotide synthesis, and highly potent compounds.
Dr. Caiding Daniel Xu, CTO of Apeloa Peptide, alongside our EU BD team, will be on-site to explore how our integrated CDMO solutions can help you accelerate therapeutics to market, expedite R&D, and improve CMC efficiency.
See you there!
